M. Belda

Debulking Surgery: Interval Debulking Surgery Versus Primary: Pros and Cons on How to Evaluate Quality

A. Bats, C. Ngô, L. Fournier, 2017 .

Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)

J. Patard, A. Hoznek, F. Saint, 2004 .

Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.

C. Genestie, F. Guyon, A. Leroux, 2022, Gynecologic oncology.